Border tax counter productive for US, may never happen: Strides

The US Republicans' plans to introduce a Border Adjustment Tax is going to be counter-productive for the United States and may never come to fruition, says Arun Kumar, Executive Vice Chairman and Managing Director at Strides Shasun."Status quo will remain and the Indian generics business will continue to grow," he said, talking about the impact the Trump government's protectionist policies may impact on the industry.Even if the tax is introduced, Strides has an exposure of only USD 100 million in the US and so will not be a big hit to company's sales, Kumar adds.Going forward, the pharma company is going to focus on its B2C business and the high cash generating verticals, he says.Watch video for more.